NCT01672762View on ClinicalTrials.gov

A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

May 25, 2012

Primary Completion Date

April 13, 2013

Study Completion Date

April 13, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ipragliflozin

oral

Trial Locations (7)

Unknown

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY